C07C 217/46
The carbon skeleton being acyclic and unsaturated
Official title: the carbon skeleton being acyclic and unsaturated
C07C217/46 (The carbon skeleton being acyclic and unsaturated) appears on 29 US grants and 34 published applications in this corpus.
Search patents in C07C- Granted patents
- 29
- Published applications
- 34
- Assignees
- 27
- Inventors
- 130
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 4 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 3 |
| 2016 | 4 | 3 |
| 2017 | 3 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 4 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions for treating neurodegenerative diseases14 May 2024US 11,981,636 B2Cognition Therapeutics, Inc.
- Compositions for treating neurodegenerative diseases4 Jan 2022US 11,214,540 B2Cognition Therapeutics, Inc.
- Etheramines based on 1,2-dialcohols22 May 2018US 9,974,985 B2BASF SE
- Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds21 Nov 2017US 9,822,116 B2OPKO Health, Inc.
- Low molecular weight cationic lipids for oligonucleotide delivery9 May 2017US 9,643,916 B2Sirna Therapeutics, Inc.
- Compositions for treating neurodegenerative diseases12 Dec 2024US 2024/0409509 A1Cognition Therapeutics, Inc.
- Compositions for treating neurodegenerative diseases10 Nov 2022US 2022/0356153 A1Cognition Therapeutics, Inc.
- Ssao inhibitors and uses thereof6 Jan 2022US 2022/0002309 A1Metacrine, Inc.
- Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof5 Aug 2021US 2021/0238192 A1Blade Therapeutics, Inc.
- Compositions for treating neurodegenerative diseases24 Sep 2020US 2020/0299234 A1Cognition Therapeutics, Inc.
Most cited
By later US patents
- Low molecular weight cationic lipids for oligonucleotide delivery92US 8,748,667 B2Sirna Therapeutics, Inc. · 2014
- Phenylcarboxylic acid derivatives19US 4,999,378 AOtsuka Pharmaceutical Co., Ltd. · 1991
- Use of substituted aminoalkoxybenzene derivatives in the control or prevention of fungal infections16US 5,106,878 AHoffmann-La Roche Inc. · 1992
- Nonaromatic fluoroallylamine MAO inhibitors10US 4,650,907 AMerrell Dow Pharmaceuticals Inc. · 1987
- Lipoxin A4 analogs10US 6,831,186 B2Schering Aktiengesellschft · 2004